Lehigh Valley Health Network (LVHN) is now offering COVID-19 remdesivir intravenous therapy exclusively at a brand-new infusion site located at 1255 S. Cedar Crest Blvd., Suite 2200. Remdesivir is an antiviral medication that helps decrease the severity of COVID-19 infection. It is most often used in symptomatic high-risk patients who are unable to take oral Paxlovid.
“We are so excited to be able to provide a place for our most vulnerable outpatient COVID-19 patients to receive remdesivir treatment. This space will ensure they are treated in a safe environment so they can focus on what’s important, recovering,” says Amy Slenker, Chief, Infectious Diseases, LVPG.